The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Molecular pharmacology
Abstract
Today&s;s pharmaceutical industry was founded on the productive interactions between the disciplines of synthetic organic chemistry and pharmacology, which occurred at the beginning of the twentieth century. This alliance has led to the production of many small organic molecules with effective therapeutic properties (Weatherall, 1990; Maxwell and Eckhardt, 1990; Silverman, 1992). In contrast, the first phase of pharmaceutical biotechnology was focused primarily on large proteins as drugs. This early phase of biotechnology is undergoing a rapid change as the second phase is spurred forward by the exciting developments in molecular biology and cell biology during the last decade (Gibbons, 1992). These developments are forging a fusion of biotechnology with the traditional methods of drug discovery.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Aronson, M. K. (1991) · Archives of Internal Medicine · doi:10.1001/archinte.1991.00400050129024 · Cited by 80
Cited by
Nicholson, J. K., Lindon, J. C., & Holmes, E. (1999) · Xenobiotica · doi:10.1080/004982599238047 · Cited by 3,895
Authors/Task Force Members, Galie, N., Hoeper, M. M., Humbert, M., Torbicki, A., Vachiery, J.-L., Barbera, J. A., Beghetti, M., Corris, P., Gaine, S., et al. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp297 · Cited by 3,846
Blum, K., Braverman, E. R., Holder, J. M., Lubar, J. F., Monastra, V. J., Miller, D., Lubar, J. O., Chen, T. J. H., & Comings, D. E. (2000) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2000.10736099 · Cited by 973
Cyclooxygenase-2 Inhibitors in Tumorigenesis (Part I)
Taketo, M. M. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.20.1529 · Cited by 757
Relling, M. V., Hancock, M. L., Rivera, G. K., Sandlund, J. T., Ribeiro, R. C., Krynetski, E. Y., Pui, C.-H., & Evans, W. E. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.23.2001 · Cited by 733
A review on cholinesterase inhibitors for Alzheimer’s disease
Anand, P., & Singh, B. (2013) · Archives of Pharmacal Research · doi:10.1007/s12272-013-0036-3 · Cited by 709
Alcohol-induced oxidative stress
Das, S. K., & Vasudevan, D. M. (2007) · Life Sciences · doi:10.1016/j.lfs.2007.05.005 · Cited by 614
Structure, function and regulation of P-glycoprotein and its clinical relevance in drug disposition
Zhou, S.-F. (2008) · Xenobiotica · doi:10.1080/00498250701867889 · Cited by 599
Chapter 4: Estrogens as Endogenous Genotoxic Agents--DNA Adducts and Mutations
Cavalieri, E., Frenkel, K., Liehr, J. G., Rogan, E., & Roy, D. (2000) · JNCI Monographs · doi:10.1093/oxfordjournals.jncimonographs.a024247 · Cited by 595
The Runner's High: Opioidergic Mechanisms in the Human Brain
Boecker, H., Sprenger, T., Spilker, M. E., Henriksen, G., Koppenhoefer, M., Wagner, K. J., Valet, M., Berthele, A., & Tolle, T. R. (2008) · Cerebral Cortex · doi:10.1093/cercor/bhn013 · Cited by 527
Wold, S., Kettaneh-Wold, N., & Skagerberg, B. (1989) · Chemometrics and Intelligent Laboratory Systems · doi:10.1016/0169-7439(89)80111-x · Cited by 532
Pathogenesis of steatohepatitis
Day, C. P. (2002) · Best Practice & Research Clinical Gastroenterology · doi:10.1053/bega.2002.0333 · Cited by 431
Rodríguez-Antona, C., Donato, M. T., Boobis, A., Edwards, R. J., Watts, P. S., Castell, J. V., & Gómez-Lechón, M.-J. (2002) · Xenobiotica · doi:10.1080/00498250210128675 · Cited by 420
Han, D. D., & Gu, H. H. (2006) · BMC Pharmacology · doi:10.1186/1471-2210-6-6 · Cited by 419
Wallentin, L. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp296 · Cited by 409
Omiecinski, C. J., Vanden Heuvel, J. P., Perdew, G. H., & Peters, J. M. (2011) · Toxicological Sciences · doi:10.1093/toxsci/kfq338 · Cited by 369
Inhibition and induction of human cytochrome P450 (CYP) enzymes
PELKONEN, O., MÄEENPÄEÄ, J., TAAVITSAINEN, P., RAUTIO, A., & RAUNIO, H. (1998) · Xenobiotica · doi:10.1080/004982598238886 · Cited by 358
The folate receptor: What does it promise in tissue-targeted therapeutics?
Salazar, M. D., & Ratnam, M. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9048-0 · Cited by 350
Molecular basis of antifolate resistance
Assaraf, Y. G. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9049-z · Cited by 338
Olfaction Under Metabolic Influences
Palouzier-Paulignan, B., Lacroix, M.-C., Aime, P., Baly, C., Caillol, M., Congar, P., Julliard, A. K., Tucker, K., & Fadool, D. A. (2012) · Chemical Senses · doi:10.1093/chemse/bjs059 · Cited by 317
The enhanced permeability retention effect: a new paradigm for drug targeting in infection
Azzopardi, E. A., Ferguson, E. L., & Thomas, D. W. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks379 · Cited by 312
Chapter 6: Estrogen Metabolism by Conjugation
Raftogianis, R., Creveling, C., Weinshilboum, R., & Weisz, J. (2000) · JNCI Monographs · doi:10.1093/oxfordjournals.jncimonographs.a024234 · Cited by 297
Vernetti, L., Gough, A., Baetz, N., Blutt, S., Broughman, J. R., Brown, J. A., Foulke-Abel, J., Hasan, N., In, J., Kelly, E., et al. (2017) · Scientific Reports · doi:10.1038/srep42296 · Cited by 271
Corradini, E., Foglia, P., Giansanti, P., Gubbiotti, R., Samperi, R., & Laganà, A. (2011) · Natural Product Research · doi:10.1080/14786419.2010.482054 · Cited by 258
Protoporphyrin IX: the Good, the Bad, and the Ugly
Sachar, M., Anderson, K. E., & Ma, X. (2016) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.115.228130 · Cited by 257
Myers, C. R., Carstens, B. P., Antholine, W. E., & Myers, J. M. (2001) · Journal of Applied Microbiology · doi:10.1046/j.1365-2672.2000.00910.x · Cited by 250
Prediction of in vivo drug clearance from in vitro data. I: Impact of inter-individual variability
Howgate, E. M., Rowland Yeo, K., Proctor, N. J., Tucker, G. T., & Rostami-Hodjegan, A. (2006) · Xenobiotica · doi:10.1080/00498250600683197 · Cited by 223
Methyiphenidate vs. amphetamine: Comparative review
Arnold, L. E. (2000) · Journal of Attention Disorders · doi:10.1177/108705470000300403 · Cited by 164
Update and perspectives on congenital disorders of glycosylation
Freeze, H. H. (2001) · Glycobiology · doi:10.1093/glycob/11.12.129r · Cited by 156
Bufotenine: Toward an understanding of possible psychoactive mechanisms
McBride, M. C. (2000) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2000.10400456 · Cited by 74
Dynamic Regulation of Proinflammatory Cytokines
Watkins, L. R., Nguyen, K. T., Lee, J. E., & Maier, S. F. (1999) · Advances in Experimental Medicine and Biology · doi:10.1007/978-0-585-37970-8_10 · Cited by 67
Biological basis for the co-morbidity between smoking and mood disorders
Mineur, Y. S., & Picciotto, M. R. (2009) · Journal of Dual Diagnosis · doi:10.1080/15504260902869964 · Cited by 51
Nelson, R. J., & Chiavegatto, S. (2000) · ILAR Journal · doi:10.1093/ilar.41.3.153 · Cited by 46
Jensen, B. A., & Hahn, M. E. (2001) · Toxicological Sciences · doi:10.1093/toxsci/64.1.41 · Cited by 44
Trends in the Top-Cited Articles on Classic Psychedelics
Lawrence, D. W., Sharma, B., Griffiths, R. R., & Carhart-Harris, R. (2021) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2021.1874573 · Cited by 35
Metadata
- Venue
- Pharmaceutical Design And Development
- Publisher
- CRC Press
- Published
- 1994-03-31
- Pages
- 138-183
- OpenAlex
- W4236670183
- Cited by
- 784
- References
- 1
- FWCI
- 171.16
- Type
- book chapter
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.